Health

Warning issued for diabetes drug

NEWS IN BRIEF — Posted Jan. 30, 2006

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

GlaxoSmithKline, in conjunction with the Food and Drug Administration, is warning physicians that rosiglitazone (Avandia) has, in a small number of patients, been linked to the onset or worsening of macular edema. A majority of the patients who developed this reaction already had peripheral edema, and, for many, the situation was resolved by reducing the dose or discontinuing the drug.

The label already advises physicians to use caution with this drug in patients who retain water, and the company plans to add information about macular edema in the future.

This condition tends to occur in conjunction with diabetic retinopathy and can lead to blurred vision and decreased color sensitivity.

The drug was approved for use in the United States in May, 1999. More than 5 million people with type 2 diabetes have taken it.

Note: This item originally appeared at http://www.ama-assn.org/amednews/2006/01/30/hlbf0130.htm.

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

■ Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

■ American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

■ Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

■ The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

■ The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

■ Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

■ Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

■ When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn